Bioray Biotech Co., Ltd (TPEX:7561)

Bioray Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	606	618	635	930	901	1,290
Market Cap Growth	-17.19%	-2.69%	-31.64%	3.17%	-30.18%	56.23%
Enterprise Value	448	515	586	911	896	1,226
Last Close Price	20.50	20.90	21.30	30.90	29.76	46.51
PE Ratio	18.81	19.17	634.18	-	1802.11	-
PS Ratio	2.72	2.78	3.15	4.85	4.73	8.72
PB Ratio	1.34	1.37	1.51	2.14	2.00	3.55
P/TBV Ratio	1.34	1.37	1.51	2.15	2.01	3.58
P/FCF Ratio	8.51	8.68	47.32	-	-	-
P/OCF Ratio	8.47	8.63	38.16	-	363.62	146.17
EV/Sales Ratio	2.01	2.31	2.90	4.75	4.70	8.29
EV/EBITDA Ratio	7.28	8.37	48.59	-	56.76	230.50
EV/EBIT Ratio	11.82	13.58	-	-	-	-
EV/FCF Ratio	6.28	7.22	43.61	-	-	-
Debt / Equity Ratio	0.10	0.10	0.20	0.16	0.22	0.15
Debt / EBITDA Ratio	0.75	0.75	4.26	13.55	4.68	4.99
Debt / FCF Ratio	0.65	0.65	6.39	-	-	-
Net Debt / Equity Ratio	-0.35	-0.35	-0.22	-0.06	-0.08	-0.20
Net Debt / EBITDA Ratio	-2.58	-2.58	-7.67	16.42	-2.42	-13.70
Net Debt / FCF Ratio	-2.23	-2.23	-6.88	2.53	0.67	11.85
Asset Turnover	0.41	0.41	0.37	0.34	0.36	0.31
Inventory Turnover	2.16	2.16	2.40	2.10	2.24	1.72
Quick Ratio	6.05	6.05	5.33	3.52	2.77	2.20
Current Ratio	7.85	7.85	6.98	5.00	3.69	2.83
Return on Equity (ROE)	7.38%	7.38%	0.23%	-2.61%	0.12%	-2.16%
Return on Assets (ROA)	4.38%	4.38%	-0.50%	-2.12%	-0.04%	-1.08%
Return on Invested Capital (ROIC)	10.07%	9.52%	-0.85%	-4.71%	-0.07%	-2.80%
Return on Capital Employed (ROCE)	7.60%	7.60%	-0.90%	-3.90%	-0.10%	-2.10%
Earnings Yield	5.32%	5.22%	0.16%	-1.24%	0.06%	-0.56%
FCF Yield	11.75%	11.53%	2.11%	-1.16%	-6.34%	-0.48%
Dividend Yield	-	-	-	-	0.67%	-
Buyback Yield / Dilution	11.42%	0.83%	0.83%	-7.37%	-4.67%	-0.14%
Total Shareholder Return	11.42%	0.83%	0.83%	-7.37%	-3.99%	-0.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.